Mid-Illinois Hematology Oncology Associates is a clinical research site located in Normal, Illinois, United States 61761.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Mid-Illinois Hematology Oncology Associates has participated in 10 clinical trials.
Therapeutic areas: Breast Cancer, Myelofibrosis (MF), Gastrointestinal Stromal Tumor.
Sponsors: NSABP Foundation Inc, AbbVie, Tragara Pharmaceuticals, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Normal
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid-Illinois Hematology Oncology Associates has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid-Illinois Hematology Oncology Associates has 10 clinical trials on record. Their work covers Breast Cancer, Myelofibrosis (MF), Gastrointestinal Stromal Tumor.
Mid-Illinois Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.